This study provided new insight into the function and molecular mechanism of the BC200/miR-150-5p/MYB positive feedback loop in MDS (Fig. 8), indicating that disrupting the BC200/miR-150-5p/MYB loop may be a novel therapeutic approach for MDS. Here, BCYRN1 is linked to myelodysplastic syndrome.